Wang C, Gu H, Cai J, Zhu C, Zheng Q, Xu H
Front Oncol. 2025; 14:1506968.
PMID: 39886667
PMC: 11779711.
DOI: 10.3389/fonc.2024.1506968.
Franken A, Kraemer A, Sicking A, Watolla M, Rivandi M, Yang L
Br J Cancer. 2023; 128(9):1742-1752.
PMID: 36823365
PMC: 10133238.
DOI: 10.1038/s41416-023-02179-0.
Zhang R, You Q, Cheng M, Ge M, Mei Q, Yang L
Front Bioeng Biotechnol. 2021; 9:783661.
PMID: 34858966
PMC: 8632441.
DOI: 10.3389/fbioe.2021.783661.
Martinez-Pena I, Hurtado P, Carmona-Ule N, Abuin C, Davila-Ibanez A, Sanchez L
Int J Mol Sci. 2021; 22(17).
PMID: 34502201
PMC: 8431683.
DOI: 10.3390/ijms22179279.
Jiang W, Han L, Yang L, Xu T, He J, Peng R
Adv Sci (Weinh). 2020; 7(22):2002259.
PMID: 33240774
PMC: 7675191.
DOI: 10.1002/advs.202002259.
Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.
Liu W, Zhang B, Chen C, Li Y, Ye X, Tang D
Thorac Cancer. 2020; 11(11):3234-3242.
PMID: 32989915
PMC: 7606026.
DOI: 10.1111/1759-7714.13654.
Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Serrano-Oviedo L, Nuncia-Cantarero M, Morcillo-Garcia S, Nieto-Jimenez C, Burgos M, Corrales-Sanchez V
Cell Oncol (Dordr). 2020; 43(3):431-444.
PMID: 32166583
PMC: 7214516.
DOI: 10.1007/s13402-020-00497-6.
Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer.
Ito M, Horimoto Y, Tokuda E, Murakami F, Uomori T, Himuro T
Med Oncol. 2019; 36(10):89.
PMID: 31520329
DOI: 10.1007/s12032-019-1314-9.
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset.
Agnoletto C, Corra F, Minotti L, Baldassari F, Crudele F, Cook W
Cancers (Basel). 2019; 11(4).
PMID: 30959764
PMC: 6521045.
DOI: 10.3390/cancers11040483.
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study.
Horimoto Y, Tokuda E, Murakami F, Uomori T, Himuro T, Nakai K
J Transl Med. 2018; 16(1):287.
PMID: 30342534
PMC: 6195982.
DOI: 10.1186/s12967-018-1663-8.
Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy.
Hu T, Zhou R, Zhao Y, Wu G
Sci Rep. 2016; 6:33376.
PMID: 27624978
PMC: 5022055.
DOI: 10.1038/srep33376.
The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells.
Kolbl A, Jeschke U, Andergassen U
Int J Mol Sci. 2016; 17(8).
PMID: 27529216
PMC: 5000705.
DOI: 10.3390/ijms17081308.
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells.
Tachtsidis A, McInnes L, Jacobsen N, Thompson E, Saunders C
Clin Exp Metastasis. 2016; 33(6):521-50.
PMID: 27189371
PMC: 4947105.
DOI: 10.1007/s10585-016-9796-8.
The potential for liquid biopsies in the precision medical treatment of breast cancer.
Forte V, Barrak D, Elhodaky M, Tung L, Snow A, Lang J
Cancer Biol Med. 2016; 13(1):19-40.
PMID: 27144060
PMC: 4850125.
DOI: 10.28092/j.issn.2095-3941.2016.0007.
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis.
Bulfoni M, Gerratana L, Del Ben F, Marzinotto S, Sorrentino M, Turetta M
Breast Cancer Res. 2016; 18(1):30.
PMID: 26961140
PMC: 4784394.
DOI: 10.1186/s13058-016-0687-3.
Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis.
Wu X, Tu Q, Faure G, Gallet P, Kohler C, Bittencourt M
Sci Rep. 2016; 6:20210.
PMID: 26831813
PMC: 4735798.
DOI: 10.1038/srep20210.
Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets.
Schindlbeck C, Andergassen U, Jueckstock J, Rack B, Janni W, Jeschke U
J Cancer Res Clin Oncol. 2016; 142(9):1883-95.
PMID: 26825607
DOI: 10.1007/s00432-016-2118-3.
Circulating tumor cells in breast cancer.
Bidard F, Proudhon C, Pierga J
Mol Oncol. 2016; 10(3):418-30.
PMID: 26809472
PMC: 5528978.
DOI: 10.1016/j.molonc.2016.01.001.
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H, Gierke B, Uppenkamp F, Behrens B, Niederacher D, Stoecklein N
PLoS One. 2015; 10(12):e0144535.
PMID: 26695635
PMC: 4687932.
DOI: 10.1371/journal.pone.0144535.
mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.
Mostert B, Sieuwerts A, Vries J, Kraan J, Lalmahomed Z, van Galen A
Mol Oncol. 2015; 9(4):920-32.
PMID: 25655581
PMC: 5528769.
DOI: 10.1016/j.molonc.2015.01.001.